IM Therapeutics is building an HLA-directed platform for new therapies. We have demonstrated early effectiveness in type 1 diabetes and are building a pipeline of targeted therapies across autoimmune diseases.
View Top Employees from IM TherapeuticsWebsite | https://www.imtherapeutics.com/ |
Revenue | $5 million |
Funding | $10 million |
Employees | 5 (5 on RocketReach) |
Founded | 2015 |
Address | 299 Washington St Suite A, Woburn, Massachusetts 01801, US |
Phone | (303) 544-2104 |
Technologies |
JavaScript,
HTML,
Twitter
+8 more
(view full list)
|
Category | Biotechnology, Drug Discovery, Pharmaceuticals, Science and Engineering, Healthcare |
SIC | 283, 28 |
NAICS | 3254, 325, 32541, 32 |
Looking for a particular IM Therapeutics employee's phone or email?
The IM Therapeutics annual revenue was $5 million in 2023.
David Alleva is the Vice President, Immunology of IM Therapeutics.
5 people are employed at IM Therapeutics.
IM Therapeutics is based in Woburn, Massachusetts.
The NAICS codes for IM Therapeutics are [3254, 325, 32541, 32].
The SIC codes for IM Therapeutics are [283, 28].
{{numFreeLookups}} free lookups per month. No credit card required.
The most common IM Therapeutics email format is [first_initial][last] (ex. jdoe@imtherapeutics.com), which is being used by 100.0% of IM Therapeutics work email addresses.
Email Format | Example | Percentage |
---|---|---|
[first_initial][last] | jdoe@imtherapeutics.com |
100.0%
|
Looking for a particular IM Therapeutics employee's phone or email?
Lorem ipsum dolor sit amet consectetur adipisicing elit.
Lorem ipsum dolor sit amet
Looking for a particular IM Therapeutics employee's phone or email?